Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death

Circulation

Volumn 99, Issue 10, 1999, Pages 1337-1343

  Mathur, Amit ^d   Sims, Harold F ^d   Gopalakrishnan, Deepika ^d   Gibson, Beverly ^d   Rinaldo, Piero ^a   Vockley, Jerry ^a   Hug, George ^b   Strauss, Arnold W ^c  

^a MAYO CLINIC   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d NONE

Author keywords

Cardiomyopathy; Death, sudden; Fatty acids; Genetics; Metabolism

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; FATTY ACID; RNA;

ARTICLE; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; DISEASE ASSOCIATION; DNA SEQUENCE; ENERGY RESOURCE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEFICIENCY; ENZYME REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HUMAN CELL; INFANT; NORTHERN BLOTTING; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 0033574265     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.10.1337     Document Type: Article

References (29)

1. Ferencz C, Neill CA. Cardiomyopathy in infancy: observations in an epidemiological study. Pediatr Cardiol. 1992;13:65-71.
2. Lewis AW, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365-369.
3. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77-82.
4. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:913-919.
5. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13: 63-69.
6. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB, Cody RJ, Fishman MC, Cox N, Kong A, Wooley CF, Seidman JG, Seidman CE. A gene defect that causes conduction system disease and dilated CM maps to chromosome 1p1-1q1. Nat Genet. 1994;7:546-551.
7. Olson TM, Michels VV, Thibodeau SN, Tai Y-S, Keating MT. Actin mutations in dilated cardiomyopathy: a heritable form of heart failure. Science. 1998;280:750-752.
8. Wallace D. Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992;61:1175-1212.
9. Strauss AW, Powell CK, Hale DE, Anderson MM, Ahuja A, Brackett JC, Sims HF. Molecular basis of human mitochondrial very long chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci U S A. 1995;92:10496-10500.
10. Hale DE, Bennett MJ. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr. 1992;121:1-11.
11. Roe CR, Coates PM. Defects of the β-oxidation spiral. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1989;1:1511-1525.
12. Boles RG, Martin SK, Blitzer MG, Rinaldo P. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. Hum Pathol. 1994;25:735-741.
13. Boles RG, Buck EA, Blitzer MG, Platt MS, Martin SK, Yoon HR, Madsen JA, Reyes-Mugica M, Rinaldo P. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem liver of 418 cases of sudden, unexpected death in the first year of life. J Pediatr. 1998;132:924-933.
14. Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindaraju DR, Rinaldo P. Diagnosis of inborn errors of metabolism in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem. 1995;41: 1109-1114.
15. Mohsen A-WA, Vockley J. Identification of the active site catalytic residue in human isovaleryl-CoA dehydrogenase. Biochemistry. 1995;34: 10146-10152.
16. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. In: Current Protocols in Molecular Biology. New York, NY: John Wiley & Sons; 1994.
17. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989;86: 2766-2770.
18. Brackett JC, Sims HF, Steiner R, Nunge M, Slaugh R, Zimmerman EM, DeMartinville B, Rinaldo P, Strauss AW. A novel mutation in medium-chain acyl-CoA dehydrogenase causes sudden neonatal death. J Clin Invest. 1994;94:1477-1483.
19. Andresen BS, Vianey-Saban C, Scholte HR, Poorthuis B, Bartlett K, Wanders RJA, Ijlst L, Olpin S, Lund H, Schroeder LD, Knudsen I, Bross P, Kristensen TJ, Bolund L, Kelvraa S, Gregersen N. Genotype-phenotype correlation in medium-chain and very-long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1997;20:50. Abstract.
20. Yamaguchi S, Indo Y, Coates PM, Hashimoto T, Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 1993;34:111-113.
21. Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T. Novel fatty acid β-oxidation enzymes in rat liver mitochondria. J Biol Chem. 1992;267: 2027-2033.
22. Eder M, Kra tle F, Dong Y, Vock P, Kieweg V, Kim J-JP, Strauss AW, Ghisla S. Human and pig kidney long chain acyl-CoA dehydrogenase: characterization and role in β-oxidation. Eur J Biochem. 1997;14: 258-556.
23. Souri M, Aoyama T, Orii K, Yamaguchi S, Hashimoto T. Mutation analysis of very-long-chain acyl-CoA dehydrogenase deficiency: identification and characterization of mutant VLCAD cDNA from four patients. Am J Hum Genet. 1996;58:97-106.
24. Andresen BS, Bross P, Vianey-Saban C, Divry P, Zabot MT, Roe CR, Nada MA, Byskov A, Kruse TA, Soren N, Kristiansen K, Knudsen I, Corydon MJ, Gregersen N. Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA: chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Mol Genet. 1996;5:1-31.
25. Andresen BS, Vianey-Saban C, Bross P, Divry P, Roe CR, Nada MA, Knudsen I, Gregersen N. The mutational spectrum in very long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1996;19: 169-172.
26. Kelly DP, Whelan AJ, Ogden ML, Alpers R, Zhang Z, Bellus G, Gregersen N, Dorland L, Strauss AW. Molecular characterization of medium-chain acyl-CoA dehydrogenase deficiency. Proc Natl Acad Sci U S A. 1990;87:9236-9240.
27. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW. The molecular basis of pediatric long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci U S A. 1995;92:841-845.
28. Kim J-JP, Wang M, Paschke R. Crystal structures of medium chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate. Proc Natl Acad Sci U S A. 1993;90:7523-7527.
29. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1988;83:927-936.